Can a simple blood test guide cancer treatment? new study investigates.

NCT ID NCT05032092

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study looks at whether analyzing the genes of a tumor (from a tissue sample or a blood test) can help doctors pick a more effective treatment for people with advanced solid cancers that have stopped responding to standard therapies. About 235 participants will have their tumor DNA tested, and researchers will track how long their next treatment keeps the cancer from growing compared to their previous therapy. The goal is to see if this personalized approach improves outcomes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

carcinoma metastatic malignant neoplasm Neoplasm Metastasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Landesklinikum Amstetten

    Amstetten, 3300, Austria

  • Landeskrankenhaus Feldkirch, Department of Internal Medicine II

    Feldkirch, Vorarlberg, 6807, Austria

  • Medical University of Graz

    Graz, 8036, Austria

  • Medical University of Innsbruck, Department of Hematology and Oncology

    Innsbruck, Tyrol, 6020, Austria

  • Ordensklinikum Linz

    Linz, Upper Austria, 4010, Austria

  • University Hospital Salzburg, Department of Internal Medicine III

    Salzburg, State of Salzburg, 5020, Austria